Litigation Support & Policy Analysis (LSPA)

Litigation Support & Policy Analysis

We bring rigorous experience in health economics methodology to the complexities of health care litigation and policy analysis. Led by Director Cara Scheibling and CEO John Schneider, PhD, our in-house experts and consultants have extensive knowledge and experience providing health economics analysis, epidemiology, and marketing and analytics advice and testimony in support of a wide range of healthcare litigation and policy applications. We are extremely knowledgeable in data sources, health insurance claims, and patient medical records.

Our expansive knowledge and experience in HEOR analytics, statistical analyses of data, syntheses of medical and economic literature, and simulation modelling add value to our litigation work. Our specific areas of expertise are listed below, and include substantial depth in a wide range of litigation, regulatory, and policy areas.

Areas of experience and expertise include:

  • Anti-trust Analysis
  • Trademark Infringement
  • Reputational Harm
  • Epidemiology & Biostatistics
  • Pennsylvania Act6
  • Affordable Care Act calculations
  • Healthcare
  • Damages
  • Contractural Disputes & Payer-Provider Disputes
  • Review and Analysis of Medical Claims & Bills to Determine Reasonable Value
  • Surveys
  • Valuations
  • Review & Analysis of Life Care Plans to Determine Reasonable Value
  • Drug Safety & Product Liability
  • Health Data Analysis & Statistical Modeling
  • Policy Research
  • Regulatory Cost-Benefit Analysis & Cost-Impact Analysis
  • Data Analysis & Simulation Modelling
  • Legislative Analytic Support Services
  • Public Health Policy
  • Insurance
  • International Health

Recent Publications

Evaluation of Health in Pregnancy grants in Scotland: a natural experiment using routine data. 2017

Assessing the impact of state “opt-out” policy on access to and costs of surgeries and other procedures requiring anesthesia services. 2017

Outcomes of Surgeries Performed in Physician Offices Compared With Ambulatory Surgery Centers and Hospital Outpatient Departments in Florida. 2017

Are financial incentives cost-effective to support smoking cessation during pregnancy? 2016

Cost impact of unexpected disposition after orthopedic ambulatory surgery associated with category of anesthesia provider. 2016

In-office magnetic resonance imaging (MRI) equipment ownership and MRI volume among medicare patients in orthopedic practices. 2015

The progressivity of health-care financing in Kenya. 2014

Organizational boundaries of medical practice: the case of physician ownership of ancillary services. 2012

Tobacco litter costs and public policy: a framework and methodology for considering the use of fees to offset abatement costs. 2011

Effects of health savings account-eligible plans on utilization and expenditures. 2011

Outcome measurement in economic evaluations of public health interventions: a role for the capability approach? 2010

International comparison of comparative effectiveness research in five jurisdictions: insights for the US. 2010

Converting to critical access status: how does it affect rural hospitals’ financial performance? 2009

Factors associated with Iowa rural hospitals’ decision to convert to critical access hospital status. 2008

The economics of specialty hospitals. 2008

Effects of specialty hospitals on the financial performance of general hospitals, 1997-2004. 2007

Effect of critical access hospital conversion on patient safety. 2007

Clinical practice guidelines and organizational adaptation: a framework for analyzing economic effects. 2006

Implementation of hospital computerized physician order entry systems in a rural state: feasibility and financial impact. 2005

What would be the effect of referral to high-volume hospitals in a largely rural state? 2004

Do NOT follow this link or you will be banned from the site!